Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | 45,000 | reported | 05 Jan 2026 | tx 1+45,000 |
| MEDICINES CO /DE | 43,000 | reported | 03 Sept 2015 | tx 166+1,374,237−991,655 |
| EYETECH PHARMACEUTICALS INC | 20,000 | reported | 19 Feb 2004 | tx 1+20,000 |
| Mineralys Therapeutics, Inc. | 6,200 | reported | 19 Feb 2026 | tx 5+113,400 |
| Ophthotech Corp. | 0 | reported | 11 Jul 2023 | tx 131+3,413,639−3,461,507 |
| AMICUS THERAPEUTICS, INC. | 0 | reported | 27 Apr 2026 | tx 57+588,173−572,594 |
| INTERCEPT PHARMACEUTICALS INC | 0 | reported | 08 Nov 2023 | tx 32+82,807−82,807 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 142,564 | 14.50 USD | |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 20,000 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 16,236 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 19,473 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 18,574 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 36,111 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 45,423 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 30,474 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 42,467 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 74,872 | — | deriv |
| 19 Feb 2026 | GRANT_AWARD | Mineralys Therapeutics, Inc. | 6,200 | 0.00 USD | |
| 19 Feb 2026 | GRANT_AWARD | Mineralys Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 05 Jan 2026 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 20,414 | 0.00 USD | |
| 05 Jun 2025 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 74,872 | 0.00 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | Mineralys Therapeutics, Inc. | 32,900 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 11,847 | 0.00 USD | |
| 06 Jun 2024 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 42,467 | 0.00 USD | deriv |
| 22 May 2024 | GRANT_AWARD | Mineralys Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 07 Mar 2024 | EXERCISE | AMICUS THERAPEUTICS, INC. | 15,000 | 2.80 USD | |
| 07 Mar 2024 | EXERCISE | AMICUS THERAPEUTICS, INC. | 15,000 | 0.00 USD | deriv |
| 08 Nov 2023 | TENDER | INTERCEPT PHARMACEUTICALS INC | 23,447 | 19.00 USD | |
| 08 Nov 2023 | OTHER | INTERCEPT PHARMACEUTICALS INC | 8,111 | 19.00 USD | |
| 08 Nov 2023 | OTHER | INTERCEPT PHARMACEUTICALS INC | 2,174 | — | deriv |
| 08 Nov 2023 | OTHER | INTERCEPT PHARMACEUTICALS INC | 2,748 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 10 May 2019.